Knowledge and preferences of substitution treatment of patients with chronic kidney disease

Authors

  • Erik Beltran Serrano Institute of Social Security and Social Services for State Workers, Hospital Regional, León, Guanajuato, Mexico https://orcid.org/0000-0002-2289-9577
  • Israel David Campos González Department of Nephrology, General Hospital Dr. Miguel Silva Morelia, Michoacán, Mexico

DOI:

https://doi.org/10.18203/2320-6012.ijrms20232116

Keywords:

Survey, Knowledge, Preferences, Peritoneal dialysis

Abstract

Several modalities of renal replacement therapy (RRT) are available for the treatment of end-stage renal disease (ESRD). Patients are likely to face complex medical decisions regarding the type of medical therapy they wish to pursue. A prospective, observational, descriptive and cross-sectional survey case series study was carried out in patients with grade 3-5 chronic kidney disease at the General Hospital ‘Dr. Miguel Silva’ without starting renal replacement therapy. We used descriptive statistics to evaluate the frequency of the categorical variables and measures of central tendency and dispersion for the quantitative variables. The total number of patients included was 20, with a mean age of 54.40±15.93 years and an age range between 24 and 78 years; 55% of the patients evaluated obtained a ‘good’ level of knowledge regarding the types of RRT (HD, PD and renal transplantation). All patients received pre-dialysis information before starting the survey. PD was the preferred RRT modality (45%), followed by kidney transplantation (35%) and finally HD (20%). The patient's level of knowledge regarding his chronic kidney disease allows him to make an informed decision about the choice of the ideal treatment. The most preferred renal replacement therapy for previously educated chronic kidney disease patients is peritoneal dialysis. The distance from the hemodialysis center to your home and work activity are important factors in choosing the type of RRT.

Metrics

Metrics Loading ...

References

Lv J, Zhang L. Renal Fibrosis: Mechanisms and Therapies. Singapore: Springer; 2019: 3-15.

Chen TK, Knicely DH, Grams ME. Chronic Kidney Disease Diagnosis and Management: A Review. JAMA. 2019;322(13):1294-304.

Romagnani P, Remuzzi G, Glassock R, Levin A, Jager KJ, Tonelli M, et al. Chronic kidney disease. Nat Rev Dis Primers. 2017;3:17088.

Mendelssohn DC, Mujais SK, Soroka SD, Brouillette J, Takano T, Barre PE, et al. A prospective evaluation of renal replacement therapy modality eligibility. Nephrol Dial Transplant. 2009;24(2):555-61.

Selby NM, Kazmi I. Peritoneal dialysis has optimal intradialytic hemodynamics and preserves residual renal function: Why isn't it better than hemodialysis? Semin Dial. 2019;32(1):3-8.

Gilbert J, Lovibond K, Mooney A, Dudley J, Guideline Committee. Renal replacement therapy: summary of NICE guidance. BMJ. 2018;363:k4303.

Chanouzas D, Ng KP, Fallouh B, Baharani J. What influences patient choice of treatment modality at the pre-dialysis stage? Nephrol Dial Transplant. 2012;27(4):1542-7.

Ameling JM, Auguste P, Ephraim PL, Lewis-Boyer L, DePasquale N, Greer RC, et al. Development of a decision aid to inform patients' and families' renal replacement therapy selection decisions. BMC Med Inform Decis Mak. 2012;12:140.

Luijtgaarden MW, Noordzij M, Tomson C, Couchoud C, Cancarini G, Ansell D, et al. Factors influencing the decision to start renal replacement therapy: results of a survey among European nephrologists. Am J Kidney Dis. 2012;60(6):940-8.

Velasco M, Quiros P, Remon C, Spanish Group for the Implementation of a Shared Decision Making Process for RRT Choice with Patient Decision Aid Tools. The Concordance between Patients' Renal Replacement Therapy Choice and Definitive Modality: Is It a Utopia? PLoS One. 2015;10(10):e0138811.

Winterbottom A, Bekker H, Mooney A. Dialysis modality selection: physician guided or patient led? Clin Kidney J. 2016;9(6):823-5.

Cassidy BP, Harwood L, Getchell LE, Smith M, Sibbald SL, Moist LM. Educational Support Around Dialysis Modality Decision Making in Patients With Chronic Kidney Disease: Qualitative Study. Can J Kidney Health Dis. 2018;5:2054358118803323.

Maaroufi A, Fafin C, Mougel S, Favre G, Seitz-Polski B, Jeribi A, et al. Patients' preferences regarding choice of end-stage renal disease treatment options. Am J Nephrol. 2013;37(4):359-69.

Liem YS, Bosch JL, Hunink MG. Preference-based quality of life of patients on renal replacement therapy: a systematic review and meta-analysis. Value Health. 2008;11(4):733-41.

Vardaro MJ, Systems HIT, AG HT, Jari A, Pentti M, Information BG, et al. Factors that determine the choice of renal replacement therapy modality in patients with chronic renal failure. 2016;2002(1):35-40.

Campos I, Arellano J, Gomez V, Quiroz J, Mariscal LA. Renal Replacement Therapy Preferences Survey: Is Allo-Hemodialysis an Acceptable Option for Patient Caregivers and Health Care Professionals? Blood Purif. 2020;49(1-2):197-201.

Carrero JJ, Hecking M, Chesnaye NC, Jager KJ. Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease. Nat Rev Nephrol. 2018;14(3):151-64.

Morton RL, Snelling P, Webster AC, Rose J, Masterson R, Johnson DW, et al. Dialysis modality preference of patients with CKD and family caregivers: a discrete-choice study. Am J Kidney Dis. 2012;60(1):102-11.

Fadem SZ, Walker DR, Abbott G, Friedman AL, Goldman R, Sexton S, et al. Satisfaction with renal replacement therapy and education: the American Association of Kidney Patients survey. Clin J Am Soc Nephrol. 2011;6(3):605-12.

Downloads

Published

2023-06-30

How to Cite

Beltran Serrano, E., & Campos González, I. D. (2023). Knowledge and preferences of substitution treatment of patients with chronic kidney disease. International Journal of Research in Medical Sciences, 11(7), 2660–2664. https://doi.org/10.18203/2320-6012.ijrms20232116

Issue

Section

Case Series